Galapagos NV logo

GLPG

Galapagos NV

$37.55

Earnings Summary

Revenue
$137.61Mn
Net Profits
$-19.03Mn
Net Profit Margins
-13.83%

Highlights

Revenue:

Galapagos NV’s revenue fell -1.55% since last year same period to $137.61Mn in the Q2 2022. On a quarterly growth basis, Galapagos NV has generated 0.93% jump in its revenue since last 3-months.

Net Profits:

Galapagos NV’s net profit jumped 70.42% since last year same period to $-19.03Mn in the Q2 2022. On a quarterly growth basis, Galapagos NV has generated -42.96% fall in its net profits since last 3-months.

Net Profit Margins:

Galapagos NV’s net profit margin jumped 69.96% since last year same period to -13.83% in the Q2 2022. On a quarterly growth basis, Galapagos NV has generated -41.65% fall in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Galapagos NV post its latest quarter earnings

EPS Estimate Current Quarter
-0.68
EPS Estimate Current Year
-0.68

Highlights

EPS Estimate Current Quarter:

Galapagos NV’s earning per share (EPS) estimates for the current quarter stand at -0.68 - a -7.06% fall from last quarter’s estimates.

EPS Estimate Current Year:

Galapagos NV’s earning per share (EPS) estimates for the current year stand at -0.68.

Key Ratios

Key ratios of the Galapagos NV post its Q1 2023 earnings

Earning Per Share (EPS)
0

Highlights

Earning Per Share (EPS):

Galapagos NV’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2023. This indicates that the Galapagos NV has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2015-09-30
4.06
-0.72
-117.73%
2015-12-31
-0.78
-0.68
12.82%

Company Information

Galapagos NV is a clinical-stage biotechnology company specialized in the discovery and development of small molecule medicines with novel modes of action.

Organisation
Galapagos NV
Headquarters
Generaal De Wittelaan L11 A3, Mechelen, Belgium, 2800
Employees
0
Industry
Health Technology
CEO
Paul Stoffels